Voyager Therapeutics (VYGR) Receivables - Net (2022 - 2025)
Voyager Therapeutics (VYGR) has disclosed Receivables - Net for 4 consecutive years, with $1.8 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 17.09% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 17.09% year-over-year, with the annual reading at $1.8 million for FY2025, 17.09% up from the prior year.
- Receivables - Net hit $1.8 million in Q4 2025 for Voyager Therapeutics, down from $3.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $80.1 million in Q4 2023 to a low of $837000.0 in Q1 2024.
- Historically, Receivables - Net has averaged $13.0 million across 4 years, with a median of $1.8 million in 2025.
- Biggest five-year swings in Receivables - Net: plummeted 98.12% in 2024 and later surged 93.91% in 2025.
- Year by year, Receivables - Net stood at $10.0 million in 2022, then surged by 701.5% to $80.1 million in 2023, then tumbled by 98.12% to $1.5 million in 2024, then rose by 17.09% to $1.8 million in 2025.
- Business Quant data shows Receivables - Net for VYGR at $1.8 million in Q4 2025, $3.2 million in Q3 2025, and $1.7 million in Q2 2025.